Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL27387251 | 1.00 | — | — | |
| Ethane SCHEMBL1953864 | 1.00 | TSHR (0.39) | TSHRCASP1 | |
| Ethane SCHEMBL35731 | 1.00 | TSHR (0.39) | TSHRCASP1 | |
| Ethane SCHEMBL2777230 | 1.00 | TSHR (0.39) | TSHRCASP1 | |
| Ethane SCHEMBL28364428 | 1.00 | TSHR (0.39) | TSHRCASP1 | |
| Ethane SCHEMBL23736000 | 1.00 | TSHR (0.39) | TSHRCASP1 | |
| Ethane SCHEMBL3416758 | 1.00 | TSHR (0.39) | TSHRCASP1 | |
| Ethane SCHEMBL20543926 | 1.00 | TSHR (0.39) | TSHRCASP1 | |
| Ethane SCHEMBL22806834 | 1.00 | TSHR (0.39) | TSHRCASP1 | |
| Ethane SCHEMBL28343156 | 1.00 | TSHR (0.39) | TSHRCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150087517-A1 | MANUFACTURING OF SPECIFICALLY TARGETING MICROCAPSULES | AGROSAVFE N.V. (BE) | 2015-03-26 | — | — | US | disclosed |
| EP-2763529-A1 | MANUFACTURING OF SPECIFICALLY TARGETING MICROCAPSULES | AGROSAVFE N.V. (BE) | 2014-08-13 | — | — | EP | disclosed |
| US-20130217572-A1 | SPECIFIC DELIVERY OF AGROCHEMICALS | Jongedijk, Erik (BE) | 2013-08-22 | — | — | US | disclosed |
| WO-2013050594-A1 | MANUFACTURING OF SPECIFICALLY TARGETING MICROCAPSULES | AGROSAVFE N.V. (BE) | 2013-04-11 | — | — | WO | disclosed |
| CN-102399526-A | Adhesive composition, circuit connection structure, semiconductor device, and solar cell module | HITACHI CHEMICAL CO LTD | 2012-04-04 | — | — | CN | disclosed |
| US-7985414-B2 | Allograft composite of a biodegradable polyurethane based on a polyisocyanate and an optionally hydroxylated biomolecule to form a matrix for embedded reinforcement of bone and/or bone substitutes; resorbable polymers having osteopromotive/osteopermissive properties; no undesirable immune response | WARSAW ORTHOPEDIC, INC. (US) | 2011-07-26 | — | — | US | disclosed |
| EP-1981440-A2 | POLYURETHANES FOR OSTEOIMPLANTS | Osteotech, Inc., (US) | 2008-10-22 | — | — | EP | disclosed |
| WO-2007084610-A2 | POLYURETHANES FOR OSTEOIMPLANTS | OSTEOTECH, INC. (US) | 2007-07-26 | — | — | WO | disclosed |
| US-20060216323-A1 | Polyurethanes for osteoimplants | WARSAW ORTHOPEDIC, INC. | 2006-09-28 | — | — | US | disclosed |
| EP-0324432-B1 | Process for preparing modified polyamides and polyamides obtainable thereby | ENICHEM SPA (IT) | 1994-07-27 | — | — | EP | disclosed |
| US-4939234-A | Polymerization of lactam polyisocyanate having the isocyanate groups blocked with lactam | MONTEDIPE, S.P.A. (IT) | 1990-07-03 | — | — | US | disclosed |
| EP-0324432-A2 | Process for preparing modified polyamides and polyamides obtainable thereby | ENICHEM S.p.A. (IT) | 1989-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060216323-A1 | Polyurethanes for osteoimplants | BMP2, BMP1, SOST | TSHR 4474/4885CASP1 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.